AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery
Posted:
Life sciences data company Apheris on Thursday announced an effort to boost the capabilities of protein AI models by uniting several pharmaceutical companies’ proprietary data. Apheris’ consortium of pharma companies is partnering with OpenFold3 — Columbia professor Mohammed AlQuraishi’s open-source dupe of AlphaFold3 — to train the model on AbbVie and Johnson & Johnson’s vast stores of structural data. The collaboration will focus on structures relevant to drug discovery, such as small molecule-protein and antibody-antigen interactions.
Technical debt comes in many forms, especially for hospitals and health systems. The larger the organization, the more complex the technology, explains David Hotchkiss, vice president and chief information and security officer for the Medical College of Wisconsin.
Read more here.
Learn how the MHRA and NICE are getting medicines to patients 3 to 6 months sooner by delivering same time decisions on licensing and value.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us